Passage BioPASG
13F holders, Q2 2026 (June 30)29holders −6
4new positions
9sold out
1famous investor
$4.88avg. 13F price*
At the end of Q2 2026, 29 institutions reported holding Passage Bio Inc. (PASG) in their 13F filings, down 6 from Q1 2026. 4 opened new positions and 9 sold out. The largest holders were Lynx1 Capital Management LP ($3.3M), Vanguard Capital Management LLC ($556K) and Balyasny Asset Management L.P. ($522K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Passage Bio Inc.
- CUSIP
- 702712209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $706K |
| Exits | 9 | $3.7M |
All 13F filers, Q1 2026 → Q2 2026: 244,398 shares bought and 626,266 shares sold, net −381,868 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| Lynx1 Capital Management LP | 0.38% | Add +8.0% | 673,759 | $3.3M |
| Vanguard Capital Management LLC | 0.00% | No change | 113,964 | $556K |
| Balyasny Asset Management L.P. | 0.00% | New | 107,025 | $522K |
| Ikarian Capital, LLC | 0.08% | Add +46.1% | 99,517 | $486K |
| Yiheng Capital Management, L.P. | 0.18% | No change | 86,097 | $420K |
| Renaissance Technologies | 0.00% | Reduce -64.2% | 47,892 | $234K |
| Erste Asset Management GmbH | 0.00% | Reduce -52.3% | 40,665 | $197K |
| Geode Capital Management, LLC | 0.00% | Reduce -10.5% | 37,026 | $181K |
| Verdad Advisers, LP | 0.14% | Add +38.9% | 30,728 | $150K |
| Boothbay Fund Management, LLC | 0.00% | Add +50.7% | 28,439 | $139K |
| BlackRock, Inc. | 0.00% | Reduce -2.4% | 27,910 | $136K |
| Acadian Asset Management LLC | 0.00% | Reduce -7.0% | 22,496 | $109K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 17,049 | $83K |
| Deltec Asset Management LLC | 0.01% | New | 15,000 | $73K |
| UBS Group AG | 0.00% | Reduce -50.7% | 13,565 | $66K |
| HRT Financial LP | 0.00% | New | 12,712 | $62K |
| Fiduciary Trust Co | 0.00% | No change | 10,750 | $52K |
| GTS Securities LLC | 0.00% | New | 10,000 | $49K |
| Morgan Stanley | 0.00% | Reduce -9.8% | 2,389 | $12K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 638 | $3K |
| Barclays PLC | 0.00% | No change | 212 | $1K |
| SBI Securities Co., Ltd. | 0.00% | Add +36.3% | 169 | $825 |
| Wells Fargo & Company | 0.00% | No change | 115 | $561 |
| JPMorgan Chase & Co. | 0.00% | No change | 15 | $73 |
| Osaic Holdings, Inc. | 0.00% | No change | 15 | $73 |
| BNP Paribas Financial Markets | 0.00% | No change | 12 | $59 |
| LRI Investments, LLC | 0.00% | No change | 12 | $59 |
| Harbour Investments, Inc. | 0.00% | No change | 3 | $15 |
| Tsfg, LLC | 0.00% | No change | 5 | $0 |
"% of holder's portfolio" is PASG's weight in each manager's 13F, not the share of Passage Bio Inc. the manager owns.